Research · Education · Human Potential
001 · ManifestoStrength Intelligence

The new standard in strength intelligence.

An editorial research platform for peptides, recovery, metabolism, sexual health, skin, sleep, and performance. Deep research. Clear insights. Smarter decisions.

300+
Compounds Researched
12,500+
Research Sources Analyzed
Live
Updated Library
IndexPeptide ResearchRecovery ScienceMetabolic HealthSleep ArchitectureEndocrine PathwaysCellular RepairNootropicsSexual HealthSkin & Cosmetic SciencePerformance Biology
02 · Intelligence Files

Intelligence files.

Privileged biological dossiers from the research archive.

Open Archive
Evidence tiersTier A· Strong evidenceTier B+· Moderate evidenceTier C+· Limited evidenceTier Emerging· Preliminary
FILE · 001Cellular Repair / Longevity

NAD+

Foundational cellular coenzyme studied for energy metabolism, mitochondrial function, DNA repair signaling, sirtuin activity, and age-associated cellular resilience.

Tier B
Confidence7.9 / 10
Sources8
Open Intelligence FileREVIEWED
FILE · 002Inflammation / Recovery

BPC-157

Body Protection Compound 157, a stable gastric pentadecapeptide studied for tissue repair, tendon/ligament healing models, GI protection, angiogenesis, and inflammation-recovery biology.

Tier B+
Confidence8.7 / 10
Sources11
Open Technical BriefVERIFIED
FILE · 003Skin / Cosmetic

GHK-Cu

Copper-binding tripeptide studied for skin remodeling, collagen and elastin support, wound-repair biology, and antioxidant signaling.

Tier B+
Confidence8.7 / 10
Sources10
Open Intelligence FileVERIFIED
FILE · 004Sexual Health

PT-141

Melanocortin receptor agonist studied for sexual desire, arousal signaling, and brain-driven sexual response.

Tier Emerging
Confidence5.4 / 10
Sources11
Open Intelligence FileACTIVE
FILE · 005Sexual Health

Kisspeptin

Reproductive signaling peptide studied for sexual health, hormone signaling, fertility biology, and sexual desire pathways.

Tier B
Confidence7.9 / 10
Sources10
Access DossierREVIEWED
FILE · 006Sleep

DSIP

Delta Sleep-Inducing Peptide studied for slow-wave sleep, sleep architecture, insomnia research, and nervous-system recovery signaling.

Tier B
Confidence7.9 / 10
Sources11
View Research FileREVIEWED
FILE · 007Skin / Cosmetic

Melanotan I

Alpha-MSH analog (afamelanotide) studied for MC1R activation, eumelanin production, light tolerance, and photoprotection biology in erythropoietic protoporphyria research.

Tier B+
Confidence8.7 / 10
Sources11
Open Technical BriefVERIFIED
FILE · 008Skin / Cosmetic

Melanotan II

Synthetic cyclic alpha-MSH analog and nonselective melanocortin receptor agonist studied for MC1R-driven pigmentation, sexual-response signaling, and neuroendocrine melanocortin pathways.

Tier B
Confidence7.9 / 10
Sources14
View Research FileREVIEWED
FILE · 009Metabolic / Weight Loss

5-Amino-1MQ

Small-molecule NNMT inhibitor studied for adipose-tissue energy metabolism, NAD+/SAM preservation, and body-composition research in preclinical obesity models.

Tier C
Confidence6.2 / 10
Sources9
View Research FileACTIVE
FILE · 010Metabolic / Weight Loss

AOD-9604

Synthetic C-terminal hGH fragment (modified 177-191) studied for lipolysis, anti-lipogenesis, and fat-metabolism research, generally well tolerated in human trials but did not reach obesity-drug efficacy.

Tier B
Confidence7.9 / 10
Sources10
Access DossierREVIEWED
FILE · 011Metabolic / Weight Loss

SLU-PP-332

Synthetic pan-ERR (α/β/γ) agonist studied as an exercise-mimetic, preclinical evidence for mitochondrial function, fatty acid oxidation, endurance, and metabolic syndrome models. Investigational; published research notes limited oral bioavailability.

Tier C
Confidence6.2 / 10
Sources7
View Research FileACTIVE
Editorial Doctrine

Privileged biological intelligence, made legible.

No hype. No miracle claims. No ecommerce pressure. Every file traces back to peer-reviewed literature, registered trials, or regulatory positions of record.

01

Research Transparency

Every breakdown is built around source-backed education.

02

Evidence Grading

Claims are separated by strength of evidence.

03

Regulatory Awareness

Safety, compliance, and status are clearly noted.

04

Education First

No hype, no miracle claims, no ecommerce pressure.

Closing Statement

Deep research.
Clear insights. Smarter decisions.

Enter the Archive